91 related articles for article (PubMed ID: 9632453)
1. Venous thrombosis--the interaction of genes and environment.
Bertina RM; Rosendaal FR
N Engl J Med; 1998 Jun; 338(25):1840-1. PubMed ID: 9632453
[No Abstract] [Full Text] [Related]
2. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
[TBL] [Abstract][Full Text] [Related]
3. Fatal cerebral venous sinus thrombosis associated with the factor V Leiden mutation and the use of oral contraceptives.
Bridey F; Wolff M; Laissy JP; Morin V; Lefebvre M; de Prost D
Thromb Haemost; 1995 Nov; 74(5):1382. PubMed ID: 8607129
[No Abstract] [Full Text] [Related]
4. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
5. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
6. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the risk of pulmonary embolism and deep vein thrombosis in the presence of factor V Leiden or prothrombin G20210A.
Ordóñez AJ; Carreira JM; Alvarez CR; Rodríguez JM; Alvarez MV; Coto E
Thromb Haemost; 2000 Feb; 83(2):352-4. PubMed ID: 10739402
[No Abstract] [Full Text] [Related]
8. Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use.
Legnani C; Palareti G; Guazzaloca G; Cosmi B; Lunghi B; Bernardi F; Coccheri S
Eur Heart J; 2002 Jun; 23(12):984-90. PubMed ID: 12069454
[TBL] [Abstract][Full Text] [Related]
9. Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis.
Kurkowska-Jastrzebska I; Wicha W; Dowzenko A; Vertun-Baranowska B; Pytlewski A; Bogusławska R; Członkowska A
Med Sci Monit; 2003 May; 9(5):CS41-5. PubMed ID: 12761462
[TBL] [Abstract][Full Text] [Related]
10. Advances in the etiology and treatment of venous thromboembolism.
Comp PC
Adv Intern Med; 1999; 44():59-89. PubMed ID: 9929705
[No Abstract] [Full Text] [Related]
11. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
[TBL] [Abstract][Full Text] [Related]
12. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
13. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
[TBL] [Abstract][Full Text] [Related]
14. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
[TBL] [Abstract][Full Text] [Related]
15. Factor V Leiden and prothrombin G20210A variant are risk factors for venous thromboembolism in the Argentinean population.
Adamczuk Y; Iglesias Varela ML; Forastiero R; Martinuzzo M; Cerrato G; Pombo G; Carreras LO
Thromb Haemost; 2000 Mar; 83(3):509-10. PubMed ID: 10744162
[No Abstract] [Full Text] [Related]
16. Cerebral vein thrombosis not related to use of oral contraceptives in a 7-year-old child carrier of the prothrombin 20210A allele.
De Stefano V; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Teofili L; Di Mario A; Leone G
Thromb Haemost; 1999 Jun; 81(6):991-2. PubMed ID: 10404783
[No Abstract] [Full Text] [Related]
17. Thrombosis: new culprits in an old disorder.
Federman DG; Moriarty JP; Kravetz JD; Kirsner RS
Panminerva Med; 2002 Jun; 44(2):107-13. PubMed ID: 12032428
[TBL] [Abstract][Full Text] [Related]
18. Coincidence of factor V Leiden mutation and a mutation in the prothrombin gene at position 20210 in a patient with puerperal cerebral venous thrombosis.
Weih M; Mehraein S; Valdueza JM; Einhäupl KM; Vetter B; Kulozik AE
Stroke; 1998 Aug; 29(8):1739-40. PubMed ID: 9707222
[No Abstract] [Full Text] [Related]
19. Prothrombin gene mutation uncommon in pulmonary embolism.
Kohlmeier RE; Cho CG; Bux RC; Guerra L; Rulon JJ; Selby DM; Gulley ML
South Med J; 2000 Nov; 93(11):1073-7. PubMed ID: 11095555
[TBL] [Abstract][Full Text] [Related]
20. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
